Hosted on MSN13d
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know
Ginkgo Bioworks Holdings, Inc. (DNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' Path
Ginkgo Bioworks faces ongoing revenue declines and high cash burn, despite cost-cutting efforts. Find out why I maintain a ...
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...
Ginkgo Bioworks price target raised to $16 from $10 at TD Cowen
TD Cowen analyst Brendan Smith raised the firm’s price target on Ginkgo Bioworks (DNA) to $16 from $10 and keeps a Buy rating on the shares.
Yahoo Finance13d
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know
Ginkgo Bioworks Holdings, Inc. (DNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...